GTX INC (70) | Human Resources (17)

Browse by Subcategory

Recent Contracts

Employment Transition Agreement between Frank Hsu, M.D. and Registrant, dated February 24, 2021 (Filed With SEC on May 6, 2021)
Non-Employee Director Compensation Policy, as amended and restated, effective March 18, 2021 (Filed With SEC on May 6, 2021)
Oncternal Therapeutics, Inc. 2021 Employment Inducement Incentive Award Plan and form of stock option agreement thereunder (Filed With SEC on February 17, 2021)
Consulting Agreement dated September 20, 2019 between Robert J. Wills. Ph.D. and Oncternal Therapeutics, Inc (Filed With SEC on March 16, 2020)
Employment Agreement dated September 12, 2019 between Oncternal Therapeutics, Inc. and James B. Breitmeyer, M.D (Filed With SEC on November 8, 2019)
Amended Oncternal Therapeutics, Inc. Annual Incentive Plan (Filed With SEC on November 8, 2019)
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Hazel M. Aker (Filed With SEC on November 8, 2019)
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Richard G. Vincent (Filed With SEC on November 8, 2019)
Employment Agreement dated September 9, 2019 between Oncternal Therapeutics, Inc. and Igor P. Bilinsky, Ph.D (Filed With SEC on November 8, 2019)
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Gunnar F. Kaufmann, Ph.D (Filed With SEC on November 8, 2019)
Employment Agreement dated August 26, 2019 between Oncternal Therapeutics, Inc. and Frank Hsu, M.D (Filed With SEC on November 8, 2019)
Form of Stock Option Agreement under the Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on April 8, 2019)
Consulting Agreement dated April 3, 2017, between Oncternal Therapeutics, Inc. and Richard G. Vincent (Filed With SEC on April 8, 2019)
Employment Letter dated January 1, 2019, between Oncternal Therapeutics, Inc. and Richard G. Vincent (Filed With SEC on April 8, 2019)
Employment Letter dated May 31, 2017, between Oncternal Therapeutics, Inc. and James B. Breitmeyer, M.D., Ph.D (Filed With SEC on April 8, 2019)
Form of Early Exercise Stock Option Agreement under the Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on April 8, 2019)
Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on April 8, 2019)